Impact of PEPFAR since 2003
Since 2003, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) has been steadfast in supporting lifesaving treatment for people living with HIV. PEPFAR is working with partners across 55 countries to sustain the gains made and accelerate progress to end HIV/AIDS as a public health threat by 2030.
Impact Tracker
26,000,000
Incrementing every 3.3 minutes
7,000,000
Incrementing every 31 minutes
Estimated lives saved by PEPFAR programs from 2003 until the Stop Work Order
Health Impact of PEPFAR
🌐 Across 55 Countries:
- HIV Treatment: PEPFAR is providing lifesaving HIV treatment for 20.6 million people, including 566,000 children, as of Sept. 30, 2024.
- Viral Suppression: 95% of adults and 89% of children on PEPFAR-supported treatment are virally suppressed.
- HIV Infections Reduction: 52% fewer new HIV infections in 2023 than in 2010 across PEPFAR-supported countries, compared with a 39% reduction globally.
- AIDS-related Deaths Decrease: 59% decrease in AIDS-related deaths in PEPFAR-supported countries, compared with 51% globally.
- HIV Prevention: PEPFAR accounts for more than 90% of pre-exposure prophylaxis (PrEP) initiations for HIV prevention globally.
- HIV Testing: In FY 2024, the program provided HIV testing services to 83.8 million people, 12 million more than in FY 2023.
- Male Circumcision: PEPFAR has provided 35.1 million voluntary medical male circumcisions for HIV prevention since 2007, including 2.7 million in FY 2024.
- Support for Young Women: PEPFAR reached 2.3 million adolescent girls and young women with comprehensive HIV prevention services in FY 2024.
PEPFAR in Visual Data
Why is PEPFAR funding valuable for Americans?
PEPFAR funding is not just an act of global altruism; it's a strategic investment in America's health security and economic interests. Here's why:
Global Health Security
By controlling HIV/AIDS globally, we reduce the risk of new variants and protect Americans from potential health threats. This proactive approach strengthens our national health security.
Economic Benefits
Healthier global populations mean stronger economies and better trading partners for the U.S. This leads to increased economic opportunities and stability for American businesses and workers.
Diplomatic Soft Power
PEPFAR enhances America's global reputation and influence, opening doors for cooperation in other areas. This soft power approach strengthens our international relationships and diplomatic efforts.
Scientific Advancements
Research funded by PEPFAR contributes to broader medical discoveries that benefit Americans. These advancements can lead to breakthroughs in treating other diseases and improving overall healthcare.
Job Creation
PEPFAR supports American jobs in healthcare, research, and international development sectors. This creates employment opportunities for Americans in various fields related to global health.
Domestic Manufacturing
PEPFAR's demand for medical supplies and pharmaceuticals stimulates U.S. manufacturing, creating jobs and fostering innovation in the healthcare industry. This strengthens our domestic production capabilities.
PEPFAR's investments generate significant economic value, including healthcare savings, increased productivity, and economic growth in partner countries that benefit the U.S. economy. This return on investment demonstrates the far-reaching impact of PEPFAR funding beyond its primary health objectives.